Monthly Performance
Quarterly Performance
As of 10/31/2017MonthYTD1 Year3 Year15 Year1Since Inception1,2

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX)

2.57%18.30%19.26%6.67%N/A7.28%

MSCI ACWI Index

2.08%19.69%23.20%7.92%N/A9.71%
As of 9/30/2017QuarterYTD1 Year3 Year15 Year1Since Inception1,2

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX)

3.13%15.34%13.77%5.46%N/A6.82%

MSCI ACWI Index

5.18%17.25%18.65%7.43%N/A9.40%

1 Annualized.
2 Fund inception date 4/4/2013.

The performance data quoted represents past performance and is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance information quoted. To obtain performance information current to the most recent month-end, please call 1.877.997.9971.

The gross and net expense ratios are 0.59% and 0.51%, respectively.*

The adviser has contractually agreed to waive certain fees/expenses to the extent that they do not exceed 0.65% for Advisor Shares. The adviser may recoup previously waived expenses that it assumed for up to two years from the end of the fiscal year in which the expenses were incurred. The adviser has also contractually agreed to waive its advisory fee from 0.24% to 0.16% through June 30, 2018.

The MSCI ACWI is a free float-adjusted market capitalization weighted index that is designed to measure the equity performance of developed and emerging markets. The MSCI ACWI covers the Large and Mid-Capitalization securities as defined by MSCI. Indices are unmanaged and have no fees. It is not possible to invest directly in an index.

*Effective 7/1/2017.


Please consider the Fund’s investment objectives, risks, charges and expenses carefully before investing. The prospectus that contains this and other information about the Fund is available by calling 1.877.997.9971 and should be read carefully prior to investing.

An investment in the Fund is subject to risks and you could lose money on your investment in the Fund. The principal risks of investing in the Fund include, but are not limited to, investing in smaller companies with limited resources and the use of predictive models. A value oriented investing style may go in and out of favor which may cause the Fund to sometimes underperform other equity funds.

Foreign securities have additional risks including currency rate changes, political and economic instability, less regulation and market liquidity. Investments in emerging markets involve even greater risks.

The adviser and sub-advisers may be unable to construct the Fund’s investment portfolio such that the intended federal tax implications, when making investment decisions with respect to individual securities, are achieved.

The Fund is exposed to the principal risks of the underlying funds in which it invests.   These risks include counterparty risk, derivatives risk, equity market risk, focused investment risk, foreign securities and currencies risk, large shareholder risk, leverage risk, liquidity risk, management and operational risk, models and data risk, political and economic risks, short sale risk and small and mid-cap company risk.  Further information about these and other risks may be found in the prospectus.

Aspiriant Risk-Managed Equity Allocation Fund is distributed by UMB Distribution Services, LLC.

Check the background of this firm on FINRA’s BrokerCheck

 

Quick Facts

Ticker Symbol

RMEAX

CUSIP

04537V105

NAV

NA

Inception Date

4/4/2013

Fund Assets

$945.9 Million
(as of 9/30/2017)

Number of Equity Holdings

737 (as of 9/30/2017)

Dividends

Distributed Annually